SNMMI issues press releases on new research, society updates and industry news for members of the press. Check back frequently to see what's new with SNMMI.

View press releases on the latest research and news from SNMMI.

Nuclear and molecular imaging are vital elements of today's medical practice, adding an additional dimension to diagnosis that can change the way diseases are understood and treated. Nuclear medicine therapies treat specific diseases, such as lymphoma or thyroid cancer, by allowing a high dose of medicine to be delivered directly to a tumor or problem area. SNMMI's fact sheets explain how nuclear medicine and molecular imaging can help diagnose and/or treat a wide range of diseases.

SNMMI publishes two peer-reviewed medical journals—The Journal of Nuclear Medicine (JNM) and The Journal of Nuclear Medicine Technology (JNMT)—which feature the latest in molecular imaging research. JNM and JNMT are the most widely read peer-reviewed publications in molecular imaging, nuclear medicine and allied disciplines.

Every month, JNM brings readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research. JNM's Newsline offers in-depth reporting on news affecting every facet of the field—the latest scientific events, government decisions, industry developments, socio-economic trends, and a broad selection of reviews from the literature.

Published quarterly, JNMT focuses on technology, quality assurance, radiation safety, and the clinical applications of nuclear medicine. Each issue features continuing education articles written by leading educators in nuclear medicine technology as well as news and updates on practice, licensure, and credentialing for nuclear medicine technologists. Practitioners from across the imaging sciences turn to JNMT for peer-reviewed information related to daily clinical practice.

SNMMI can connect you with subject-matter experts on a variety of topics who are ready to respond to tight deadlines. Contact Laurie Callahan, SNMMI's acting associate director of public relations, at lcallahan@snmmi.org or at (703) 652-6773, to set up an interview with SNMMI's leadership or with one of its many experts on oncology, brain disease, heart disease, radiopharmaceuticals, reimbursement and more.

SNMMI Leadership

• Sally W. Schwarz, MS, RPh, BCNP
  SNMMI President
• Bennett S. Greenspan, MD, FACNM, FACR
  SNMMI President-Elect
• Satoshi Minoshima, MD, PhD
  SNMMI Vice President-Elect
• Hossein Jadvar, MD, PhD, MPH, MBA, FACNM
  SNMMI Immediate Past President

SNMMI-TS Leadership

• Sara G. Johnson, MBA, CNMT, NCT, FSNMMI-TS
  SNMMI-TS President
• Kathleen M. Krisak, BS, CNMT, FSNMMI-TS 
  SNMMI-TS President-Elect
• Aaron Scott, MIS, CNMT, NMAA, FSNMMI-TS
  SNMMI-TS Immediate Past President

Join SNMMI on our social media networks to stay updated on the latest from the society and the nuclear medicine and molecular imaging field.

SNMMI 2017 Annual Meeting News, Announcements, Research
June 10-14, Denver, Colorado
Colorado Convention Center

Scientific Research - (All releases embargoed until Monday, June 12, 2017, at 12:30 pm MDT; contact Laurie Callahan at lcallahan@snmmi.org, 703-652-6773-office, 571-294-1973-cell, if you need embargoed releases in advance)

Categories

Cardiovascular

General Clinical Specialties

Instrumentation and Data Analysis

Molecular Targeting Probes

Neurosciences

Oncology - Basic

Oncology - Clinical

Also announced at the Annual Meeting: SNMMI Image of the Year, SNMMI/SNMMI-TS Officers, and Awards